Evidence map›Paper›PMID 26924577›Full record

ArticleCell2016

Cytotoxic T Cells Use Mechanical Force to Potentiate Target Cell Killing.

Roshni Basu, Benjamin M Whitlock, Julien Husson, Audrey Le Floc'h, Weiyang Jin, Alon Oyler-Yaniv, Farokh Dotiwala, Gregory Giannone, Claire Hivroz, Nicolas Biais and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 274 papers.

0numbers the graph read from it
0cells of the map it votes in
274citing papers in PubMed
18.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

274 citing papers in PubMed, 465 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

214 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 2 countries.

Roshni BasuImmunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Benjamin M WhitlockBiochemistry and Molecular Biology Graduate Program, Weill-Cornell Medical College, New York, NY 10065, USA.
Julien HussonHydrodynamics Laboratory (LadHyX), Department of Mechanics, Ecole Polytechnique, Palaiseau 91128, France.
Audrey Le Floc'hImmunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Weiyang JinDepartment of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
Alon Oyler-YanivComputational Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Farokh DotiwalaProgram in Cellular and Molecular Medicine, Harvard Medical School, Boston, MA 02115, USA.
Gregory GiannoneCNRS, University of Bordeaux, Interdisciplinary Institute for Neuroscience, UMR 5297, Bordeaux 33000, France.
Claire HivrozInstitute Curie, INSERM U932, PSL Research University, Paris 75005, France.
Nicolas BiaisDepartment of Biology, Brooklyn College of the City University of New York, New York, NY 11201, USA.
Judy LiebermanProgram in Cellular and Molecular Medicine, Harvard Medical School, Boston, MA 02115, USA.
Lance C KamDepartment of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
Morgan HuseImmunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. Electronic address: husem@mskcc.org.
Memorial Sloan Kettering Cancer Center · USColumbia University · USHarvard University · USCentre National de la Recherche Scientifique · FRCity University of New York · USCornell University · USÉcole Polytechnique · FRInserm · FR

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Nanomedicine development center for mechanobiologyPN2EY016586 · NEI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DUSTIN, MICHAEL LORAN · 2005 to 2014
$23.0M
Synaptic Control of Cytotoxic T cell FunctionR01AI087644 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI HUSE, MORGAN A · 2010 to 2025
$7.3M
Spatial coordination of CD28 and TCR signalingR01AI088377 · NIAID · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI KAM, LANCE C · 2010 to 2013
$1.3M
Mechanobiology of Neisseria MicrocoloniesSC2AI116566 · NIAID · BROOKLYN COLLEGE · PI BIAIS, NICOLAS · 2014 to 2016
$471k
NCI NIH HHS P30 CA008748NCI NIH HHS P30-CA008748NEI NIH HHS PN2 EY016586NEI NIH HHS PN2-EY016586NIAID NIH HHS R01 AI087644NIAID NIH HHS R01-AI087644NIAID NIH HHS R01 AI088377NIAID NIH HHS R01-AI088377NIAID NIH HHS SC2 AI116566
6 · The paper itself

Abstract

The immunological synapse formed between a cytotoxic T lymphocyte (CTL) and an infected or transformed target cell is a physically active structure capable of exerting mechanical force. Here, we investigated whether synaptic forces promote the destruction of target cells. CTLs kill by secreting toxic proteases and the pore forming protein perforin into the synapse. Biophysical experiments revealed a striking correlation between the magnitude of force exertion across the synapse and the speed of perforin pore formation on the target cell, implying that force potentiates cytotoxicity by enhancing perforin activity. Consistent with this interpretation, we found that increasing target cell tension augmented pore formation by perforin and killing by CTLs. Our data also indicate that CTLs coordinate perforin release and force exertion in space and time. These results reveal an unappreciated physical dimension to lymphocyte function and demonstrate that cells use mechanical forces to control the activity of outgoing chemical signals.

Indexed as

Immunological SynapsesAnimalsBiomechanical PhenomenaCell DegranulationCell Line, TumorMicePerforinPhosphatidylinositol 3-KinasesT-Lymphocytes, CytotoxicPerforinPhosphatidylinositol 3-Kinases

Identifiers

PMID26924577
PMCPMC4808403
OpenAlexW2280722998

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.